Current Legal Status: Sermorelin in 2026
Sermorelin has a unique legal advantage: it is the only commonly used GH peptide with a prior FDA approval. This former approval provides a stronger legal foundation for compounding pharmacies to produce it and for doctors to prescribe it.
FDA History
| Event | Date | Detail |
|---|---|---|
| FDA approval (Geref) | 1997 | Approved for GH deficiency diagnosis and treatment in children |
| Market availability | 1997-2008 | Available as brand-name pharmaceutical |
| Geref discontinued | ~2008 | Voluntarily withdrawn by EMD Serono for commercial reasons |
| Compounding production | 2008-present | Compounding pharmacies fill the gap |
What “Previously Approved” Means
Sermorelin’s prior FDA approval is legally significant:
- Established safety profile — the FDA reviewed clinical trial data and determined sermorelin was safe enough to approve
- Compounding legal standing — compounding pharmacies have stronger legal ground to produce previously-approved compounds compared to never-approved compounds like BPC-157
- Prescribing comfort — doctors are more comfortable prescribing a compound with FDA precedent
- Category 2 protection — sermorelin is less likely to be placed on the FDA’s Category 2 list because it has prior approval history
Current Access
Compounding Pharmacy (Most Common)
Sermorelin is widely available from compounding pharmacies and represents the most established clinical peptide for GH optimization:
| Feature | Details |
|---|---|
| Prescription required | Yes |
| Cost | $100-250/month |
| Common formulations | Sermorelin alone, Sermorelin + GHRP-2, Sermorelin + GHRP-6 |
| Quality | Pharmacy-grade, USP standards |
| Availability | Broadly available nationwide |
Research Chemical
| Feature | Details |
|---|---|
| Prescription required | No |
| Cost | $25-50 per vial (2mg) |
| Quality | Varies by vendor |
| Availability | Widely available |
Telehealth + Compounding
Many telehealth anti-aging platforms offer sermorelin as a starter GH peptide:
- Lower barrier to entry than CJC-1295/Ipamorelin (more prescriber familiarity)
- Often the first peptide prescribed to new patients
- Cost typically $200-350/month including consultation and product
Comparison to Other GH Peptides: Legal Status
| Compound | Prior FDA Approval | Compounding Available | Category 2 Risk | Legal Strength |
|---|---|---|---|---|
| Sermorelin | Yes (Geref) | Yes | Low | Strongest |
| Tesamorelin | Yes (Egrifta SV) | Limited | Low | Strong |
| CJC-1295 | No | Yes | Medium | Moderate |
| Ipamorelin | No | Yes | Medium | Moderate |
| MK-677 | No | Rare | Low | Moderate |
| GHRP-2/GHRP-6 | No | Yes | Medium | Moderate |
Sermorelin’s prior FDA approval makes it the legally safest GH peptide for clinical use.
WADA Prohibition
| Detail | Status |
|---|---|
| WADA category | S2 — Growth Hormone Releasing Hormones |
| Timing | Prohibited at all times |
| Detection | Yes — urine testing |
| TUE possible | Theoretically (prior FDA approval), but rarely granted for GH peptides |
Who Sermorelin Is Best For (Legally)
Sermorelin is the ideal first-choice GH peptide for people who want the most legally defensible option:
- Risk-averse users who want a compound with FDA precedent
- People who prefer compounding pharmacy quality over research chemicals
- New patients starting GH optimization — most prescribers are comfortable with sermorelin
- Insurance considerations — some plans may cover sermorelin for documented GH deficiency (more likely than covering CJC-1295/Ipamorelin)
Related Resources
- Sermorelin Protocol — dosing and administration guide
- Tesamorelin vs Sermorelin vs Ipamorelin — GH peptide comparison
- Growth Hormone Peptides Compared — all GH options
- CJC-1295 Legal Status — CJC-1295 regulatory guide
- Peptide Legality & FDA Status Guide — complete overview
Frequently Asked Questions
Is sermorelin FDA-approved? +
Sermorelin was previously FDA-approved under the brand name Geref for diagnosing and treating growth hormone deficiency in children. However, Geref was voluntarily discontinued by the manufacturer (EMD Serono) for commercial reasons — not safety concerns. This means sermorelin has an FDA safety record but is no longer available as a brand-name pharmaceutical product. It is widely available from compounding pharmacies.
Can I get sermorelin from a compounding pharmacy? +
Yes. Sermorelin is one of the most readily available peptides from compounding pharmacies. Because it has a prior FDA approval history, compounding pharmacies have strong legal standing to produce it. It is commonly prescribed by anti-aging and wellness clinics, often in combination with other GH peptides.
Is sermorelin a controlled substance? +
No. Sermorelin is not a controlled substance and is not scheduled by the DEA. It requires a prescription when obtained from a compounding pharmacy, but it is also available as a research chemical without a prescription.
Why was Geref discontinued? +
EMD Serono discontinued Geref for commercial reasons — the market for pediatric GH deficiency was small, and synthetic GH (Genotropin, Humatrope, etc.) dominated the treatment landscape. The discontinuation was not related to safety concerns. Sermorelin's safety profile was well-established through its FDA approval process.
Is sermorelin banned in sports? +
Yes. Sermorelin is on the WADA Prohibited List under S2 as a Growth Hormone Releasing Hormone (GHRH) and growth hormone secretagogue. It is prohibited at all times. Tested athletes cannot use sermorelin regardless of whether it is prescribed by a doctor.